Navigation Links
Cytopia Merger with Toronto-based YM BioSciences Inc.
Date:10/5/2009

f pain. AeroLEF met all endpoints in a randomized Phase II trial and is currently being prepared for late-stage development internationally.

For further information please visit our website at: www.cytopia.com.au

For information on YM Biosciences, please visit their website at www.ymbiosciences.com

(i)The Implementation Agreement provides for Cytopia to use commercially reasonable endeavours to ensure that each holder of a Cytopia Option agrees to the cancellation of the Cytopia options held by that holder. Unless all holders of Cytopia Options agree to the cancellation of their options, Cytopia will be required to propound the Option Scheme.

(ii)This is based on a 20 day VWAP of Cytopia and YM on 25 September 2009 of A$0.1276 and C$1.8435 respectively using an $A/$Canadian exchange rate of 0.9469.

(iii)The Effective Date is the day upon which the Schemes become effective by lodgement of the Court order with ASIC

(iv)Cytopia is required to obtain the consent by or on behalf of the Commonwealth of Australia to its proposed change in control (as the grantee company) under two specific Grants.

SOURCE Cytopia Ltd.


'/>"/>
SOURCE Cytopia Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
2. Cytopia Presentation on VDA CYT997 at AACR Conference
3. Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference
4. Cytopia Letter to Progen Shareholders
5. Cytopia and Other Progen Shareholders Maintain Call for Meeting
6. Presentation on Cytopias JAK2 Inhibitor Program in Myeloproliferative Disorders
7. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
8. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
9. Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger
10. Schering-Plough Shareholders Approve Merger With Merck
11. TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:9/22/2014)... Sept. 22, 2014  WIRB-Copernicus Group (WCG), the ... services for clinical research, announced today that its ... been reaccredited by the Association for the Accreditation ... to improve safeguards for clinical research participants. ... Deieso , Ph.D., commented, "It is of utmost ...
(Date:9/21/2014)... the University of Basel in Switzerland have succeeded ... charged molecule for the first time. These extremely ... of molecular properties and may also contribute to ... The results were published in the scientific journal ... of the interaction between matter and light, is ...
(Date:9/20/2014)... Netherlands (PRWEB) September 20, 2014 ... technologies to perform a groundbreaking surgery at the specialized ... the mare's superficial digital flexor tendon was ruptured 90% ... kind of injury is a death sentence for a ... America stem cell treatments . This revolutionary ...
Breaking Biology Technology:Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Uncovering the forbidden side of molecules 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 3
... 8 Concentric Medical, Inc., the global leader in ... announced that it has completed a $15 million round ... venture capital firm New Enterprise Associates, Inc. (NEA) and ... at Concentric over the last several months made the ...
... Technologies, Inc. (Nasdaq: PMTI ), a ... cosmetic treatments, today announced the termination of its ... AB (OMX Nordic Exchange, Stockholm Mid Cap:QMED), a ... The international distribution agreement was originally entered ...
... N.J., Jan. 7 Par Pharmaceutical Companies, Inc. (NYSE: ... Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at ... The audio-only live webcast will be accessible through the J.P. ... the Par website at www.parpharm.com . A replay ...
Cached Biology Technology:Concentric Medical Closes on $15 Million Financing 2Palomar and Q-MED AB Terminate International Distribution Agreement 2Palomar and Q-MED AB Terminate International Distribution Agreement 3Palomar and Q-MED AB Terminate International Distribution Agreement 4Palomar and Q-MED AB Terminate International Distribution Agreement 5
(Date:9/22/2014)... their own "antifreeze" proteins to survive in the ... effect, researchers report: The protein-bound ice crystals that ... temperatures warm. , The finding is reported ... of Sciences . , "We discovered what appears ... of antifreeze proteins in Antarctic notothenioid fishes," said ...
(Date:9/22/2014)... institutions in the country selected by the National ... BEST Award a $2 million grant designed ... biomedical sciences graduate trainees to career opportunities that ... traditionally taken. , The award funds development of ... (iJOBs) program. It includes courses, seminars, shadowing, mentoring ...
(Date:9/22/2014)... this image burn in Khabarovsk Krai, a territory occupying the ... accompanied by plumes of smoke mark active fires. The smoke, ... towards the Sea of Okhotsk. Taiga and tundra ... inhabit the central depression, and deciduous forests are the natural ... in Russia in the summer, the 2014 wildfire season appears ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3Rutgers receives $2 million grant to prepare biomedical students for roles in industry 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 3
... it comes to gene sequencing and personalized medicine for cancer, ... are relatively easy to target with drugs and plenty of ... University of Michigan Comprehensive Cancer Center researchers assess the complete ... are acting up in a particular tumor. They go on ...
... Athens, Ga. When Li Tan approached his colleagues at ... collected, they initially seemed convinced that his experiment had become ... Tan was examining some of the sugars, proteins and ... structural support and protection that allow plants to grow. Yet ...
... 5 February 2013 EMBO and the Federation of European ... Institut Curie in Paris, France, as the winner of the ... Professor Almouzni has been recognized for her outstanding contributions to ... in promoting epigenetics in Europe, and her active role in ...
Cached Biology News:Study finds potential to match tumors with known cancer drugs 2Study finds potential to match tumors with known cancer drugs 3Newly discovered plant structure may lead to improved biofuel processing 2Newly discovered plant structure may lead to improved biofuel processing 3Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award 2Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award 3
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
... Sf-900 II SFM.Sf21 Cells ... Spodoptera frugiperda (Fall Armyworm) ... The Sf21 cells are ... culture in Sf-900 II ...
Biology Products: